Back to funds
View filing
DEERFIELD MANAGEMENT COMPANY, L.P.
hedge fundUpdated 27 days agoManaged by Deerfield Management Company, L.P. (Series C) • Latest filing Q2 2026
Portfolio value
$9.6B
Q2 2026
Filings
17
Quarterly 13F history
Top-10 concentration
100.0%
Weight of largest holdings
Annualized return
18.6%
Implied from 13F holdings
Portfolio value history
13F-disclosed portfolio value over 17 quarters
Show data table
| Period | Portfolio value |
|---|---|
| Q2 2022 | $4.8B |
| Q3 2022 | $5B |
| Q4 2022 | $4.8B |
| Q1 2023 | $4.5B |
| Q2 2023 | $4.7B |
| Q3 2023 | $4.5B |
| Q4 2023 | $5.4B |
| Q1 2024 | $5.7B |
| Q2 2024 | $6B |
| Q3 2024 | $6.7B |
| Q4 2024 | $5.3B |
| Q1 2025 | $5.1B |
| Q2 2025 | $5.5B |
| Q3 2025 | $6.6B |
| Q4 2025 | $7.8B |
| Q1 2026 | $8.5B |
| Q2 2026 | $9.6B |
Top holdings
82 positions as of Q2 2026
| # | Stock | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|---|
| 1 | ? N/A NUVALENT INC | $2.1B | 17.25M | 22.22% | Unchanged |
| 2 | ? N/A BROOKDALE SR LIVING INC | $585.7M | 306.88M | 6.11% | Unchanged |
| 3 | R RVMDW REVOLUTION MEDICINES INC | $448M | 2.39M | 4.67% | Added(+4.1%) |
| 4 | P PRAX PRAXIS PRECISION MEDICINES I | $322.5M | 963.4K | 3.36% | Unchanged |
| 5 | V VTRS VIATRIS INC | $320.9M | 20.21M | 3.35% | Unchanged |
| 6 | C CNC CENTENE CORP DEL | $314.6M | 4.90M | 3.28% | Trimmed(-17.2%) |
| 7 | ? N/A REVOLUTION MEDICINES INC | $251.7M | 200.00M | 2.63% | — |
| 8 | U UTHR UNITED THERAPEUTICS CORP DEL | $247.6M | 457.0K | 2.58% | Unchanged |
| 9 | ? N/A ARROWHEAD PHARMACEUTICALS IN | $240.5M | 200.00M | 2.51% | Unchanged |
| 10 | L LEGN LEGEND BIOTECH CORP | $235M | 8.14M | 2.45% | Added(+5.8%) |
| 11 | C COGT COGENT BIOSCIENCES INC | $193.7M | 5.01M | 2.02% | Trimmed(-44.6%) |
| 12 | G GNMSF GENMAB A/S | $188.6M | 6.87M | 1.97% | Added(+178.8%) |
| 13 | B BKD BROOKDALE SR LIVING INC | $187.2M | 11.64M | 1.95% | Unchanged |
| 14 | V VERA VERA THERAPEUTICS INC | $168.1M | 3.92M | 1.75% | Added(+5.2%) |
| 15 | I IONS IONIS PHARMACEUTICALS INC | $157M | 1.98M | 1.64% | Unchanged |
| 16 | C CELC CELCUITY INC | $151.8M | 1.45M | 1.58% | Trimmed(-15.3%) |
| 17 | B BCRX BIOCRYST PHARMACEUTICALS INC | $151M | 15.10M | 1.57% | Added(+0.4%) |
| 18 | N NAMSW NEWAMSTERDAM PHARMA COMPANY | $144.5M | 4.26M | 1.51% | Unchanged |
| 19 | A ACHC ACADIA HEALTHCARE COMPANY IN | $133.5M | 4.52M | 1.39% | Unchanged |
| 20 | T TNGX TANGO THERAPEUTICS INC | $131M | 4.19M | 1.37% | Added(+1.1%) |